Company Filing History:
Years Active: 2003
Title: Innovations of Tracy Huening in HIV Treatment
Introduction
Tracy Huening is a notable inventor based in Madison, NJ, who has made significant contributions to the field of HIV treatment. With a total of two patents to his name, his work focuses on developing compounds that inhibit HIV protease and replication.
Latest Patents
Huening's latest patents include "Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides and uses thereof" and "Alpha-hydroxy-gamma-[[[carbocyclic-or heterocyclic-substituted]amino]carbonyl]alkanamide derivatives and uses thereof." These compounds are designed to be effective against HIV viral mutants that are resistant to current protease inhibitors. They are useful in the prevention and treatment of HIV infection and AIDS, either as standalone compounds or in combination with other antiviral agents.
Career Highlights
Tracy Huening is currently employed at Merck & Company, Inc., where he continues to innovate in the pharmaceutical field. His research has the potential to significantly impact the treatment landscape for HIV and AIDS.
Collaborations
Some of his notable coworkers include James R. Tata and Thomas A. Rano, who have collaborated with him on various projects related to HIV treatment.
Conclusion
Tracy Huening's work exemplifies the critical role of innovation in combating HIV and AIDS. His patents represent a significant advancement in the search for effective treatments against this global health challenge.